A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma.
Chanudet
E
E
Huang
Y
Y
Ichimura
K
K
Dong
G
G
Hamoudi
R A
RA
Radford
J
J
Wotherspoon
A C
AC
Isaacson
P G
PG
Ferry
J
J
Du
M-Q
MQ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D019175:DNA Methylation / Q000235:genetics*; D004268:DNA-Binding Proteins; D005260:Female; D017353:Gene Deletion; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000235:genetics* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics*; D011379:Prognosis; D011401:Promoter Regions, Genetic / Q000235:genetics*; D015996:Survival Rate; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3
D004268:DNA-Binding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; C076529:TNFAIP3 protein, human; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3